Literature DB >> 35241626

Association of opioid exposure before surgery with opioid consumption after surgery.

Mark C Bicket1,2,3, Vidhya Gunaseelan4,3, Pooja Lagisetty5,6, Anne C Fernandez7, Amy Bohnert4,2,6, Elizabeth Assenmacher8, Melwyn Sequeira9, Michael J Englesbe3,10, Chad M Brummett4,3, Jennifer F Waljee3,10.   

Abstract

OBJECTIVE: To determine the effect of prescription opioid use in the year before surgery on opioid consumption after surgery.
BACKGROUND: Recently developed postoperative opioid prescribing guidelines rely on data from opioid-naïve patients. However, opioid use in the USA is common, and the impact of prior opioid exposure on the consumption of opioids after surgery is unclear.
METHODS: Population-based cohort study of 26,001 adults 18 years of age and older who underwent one of nine elective general or gynecologic surgical procedures between January 1, 2017 and October 31, 2019, with prospectively collected patient-reported data from the Michigan Surgical Quality Collaborative (MSQC) linked to state prescription drug monitoring program at 70 MSQC-participating hospitals on 30-day patient-reported opioid consumption in oral morphine equivalents (OME) (primary outcome).
RESULTS: Compared with opioid-naïve participants, opioid-exposed participants (26% of sample) consumed more prescription opioids after surgery (adjusted OME difference 12, 95% CI 10 to 14). Greater opioid exposure was associated with higher postoperative consumption in a dose-dependent manner, with chronic users reporting the greatest consumption (additional OMEs 32, 95% CI 21 to 42). However, for eight of nine procedures, 90% of opioid-exposed participants consumed ≤150 OMEs. Among those receiving perioperative prescriptions, opioid-exposed participants had higher likelihood of refill (adjusted OR 4.7, 95% CI 4.4 to 5.1), number of refills (adjusted incidence rate ratio 4.0, 95% CI 3.7 to 4.3), and average refill amount (adjusted OME difference 333, 95% CI 292 to 374)).
CONCLUSIONS: Preoperative opioid use is associated with small increases in patient-reported opioid consumption after surgery for most patients, though greater differences exist for patients with chronic use. For most patients with preoperative opioid exposure, existing guidelines may meet their postoperative needs. However, guidelines may need tailoring for patients with chronic use, and providers should anticipate a higher likelihood of postoperative refills for all opioid-exposed patients. © American Society of Regional Anesthesia & Pain Medicine 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acute pain; analgesics, opioid; outcome assessment, health care; pain, postoperative

Mesh:

Substances:

Year:  2022        PMID: 35241626      PMCID: PMC9035103          DOI: 10.1136/rapm-2021-103388

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   5.564


  21 in total

1.  The Association Between Preoperative Opioid Exposure and Prolonged Postoperative Use.

Authors:  Charles Katzman; Emily C Harker; Rizwan Ahmed; Charles A Keilin; Joceline V Vu; David C Cron; Vidhya Gunaseelan; Yen-Ling Lai; Chad M Brummett; Michael J Englesbe; Jennifer F Waljee
Journal:  Ann Surg       Date:  2020-05-18       Impact factor: 12.969

2.  Postoperative Opioid Prescription Reduction Strategy in a Regional Healthcare System.

Authors:  Richard Frazee; Emily Garmon; Claire Isbell; Erin Bird; Harry Papaconstantinou
Journal:  J Am Coll Surg       Date:  2020-03-02       Impact factor: 6.113

Review 3.  Inappropriate opioid prescription after surgery.

Authors:  Mark D Neuman; Brian T Bateman; Hannah Wunsch
Journal:  Lancet       Date:  2019-04-13       Impact factor: 79.321

4.  Care Coordination for Patients on Chronic Opioid Therapy Following Surgery: A Cohort Study.

Authors:  Pooja Lagisetty; Amy Bohnert; Jenna Goesling; Hsou Mei Hu; Breanna Travis; Kiran Lagisetty; Chad M Brummett; Michael J Englesbe; Jennifer Waljee
Journal:  Ann Surg       Date:  2020-08       Impact factor: 12.969

5.  Variations in prescription drug monitoring program use by prescriber specialty.

Authors:  Benjamin C Sun; Nicoleta Lupulescu-Mann; Christina J Charlesworth; Hyunjee Kim; Daniel M Hartung; Richard A Deyo; K John McConnell
Journal:  J Subst Abuse Treat       Date:  2018-08-17

6.  Prevalence of Preoperative Opioid Use and Characteristics Associated With Opioid Use Among Patients Presenting for Surgery.

Authors:  Paul E Hilliard; Jennifer Waljee; Stephanie Moser; Lynn Metz; Michael Mathis; Jenna Goesling; David Cron; Daniel J Clauw; Michael Englesbe; Goncalo Abecasis; Chad M Brummett
Journal:  JAMA Surg       Date:  2018-10-01       Impact factor: 14.766

7.  Surgeon Variation in Complications With Minimally Invasive and Open Colectomy: Results From the Michigan Surgical Quality Collaborative.

Authors:  Mark A Healy; Scott E Regenbogen; Arielle E Kanters; Pasithorn A Suwanabol; Oliver A Varban; Darrell A Campbell; Justin B Dimick; John C Byrn
Journal:  JAMA Surg       Date:  2017-09-01       Impact factor: 14.766

8.  Assessment of a quality improvement intervention to decrease opioid prescribing in a regional health system.

Authors:  Craig S Brown; Joceline V Vu; Ryan A Howard; Vidhya Gunaseelan; Chad M Brummett; Jennifer Waljee; Michael Englesbe
Journal:  BMJ Qual Saf       Date:  2020-09-16       Impact factor: 7.035

9.  Classifying Preoperative Opioid Use for Surgical Care.

Authors:  Joceline V Vu; David C Cron; Jay S Lee; Vidhya Gunaseelan; Pooja Lagisetty; Matthew Wixson; Michael J Englesbe; Chad M Brummett; Jennifer F Waljee
Journal:  Ann Surg       Date:  2020-06       Impact factor: 13.787

10.  Tolerance to Opioid-Induced Respiratory Depression in Chronic High-Dose Opioid Users: A Model-Based Comparison With Opioid-Naïve Individuals.

Authors:  Marijke Hyke Algera; Erik Olofsen; Laurence Moss; Robert L Dobbins; Marieke Niesters; Monique van Velzen; Geert Jan Groeneveld; Jules Heuberger; Celine M Laffont; Albert Dahan
Journal:  Clin Pharmacol Ther       Date:  2020-10-05       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.